The role of E-cadherin in the motility and invasion of implantation site intermediate trophoblast

Placenta

Volumn 23, Issue 10, 2002, Pages 706-715

  Shih, Ie Ming ^a   Hsu, Mei Yu ^b   Oldt III, Robert J ^a   Herlyn, Meenhard ^b   Gearhart, John D ^a   Kurman, Robert J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; UVOMORULIN; CADHERIN; RECOMBINANT PROTEIN;

ARTICLE; CELL ADHESION; CELL INVASION; CELL LINE; CELL MOTILITY; CELL SHAPE; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPEROXIDASE STAINING; IN VITRO STUDY; PLACENTA DEVELOPMENT; PLACENTA FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TROPHOBLAST; VIRUS RECOMBINANT; WESTERN BLOTTING; ADENOVIRUS; CELL MOTION; CYTOLOGY; FEMALE; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; NIDATION; PHYSIOLOGY; PREGNANCY;

ADENOVIRIDAE; CADHERINS; CELL LINE; CELL MOVEMENT; EMBRYO IMPLANTATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VECTORS; HUMANS; PREGNANCY; RECOMBINANT PROTEINS; TRANSFECTION; TROPHOBLASTS;

EID: 0036834572     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(02)90864-7     Document Type: Article

References (48)

1. Behrens J, Marecl MM & Van Roy FM (1987) Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol, 108, 2435-2447.
2. Benirschke K & Kaufmann P (1995) Nonvillous parts of the placenta. In Pathology of the human placenta (Eds) Benirschke K & Kaufmann P, pp. 182-267. New York: Springer-Verlag.
3. Bukholm IK, Nesland JM & Borresen-Dale A-L (2000) Re-expression of E-cadherin, α-catenin and β-catenin, but not of γ-catenin, in metastatic tissue from breast cancer patients. J Pathol, 190, 15-19.
4. Burrows TD, King A & Loke YW (1994) Expression of adhesion molecules by endovascular trophoblast and decidual endothelial cells: implications for vascular invasion during implantation. Placenta, 15, 21-33.
5. Cowley GP & Smith ME (1995) Modulation of E-cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int J Cancer, 60, 325-329.
6. Cross JC, Werb Z & Fisher SJ (1994) Implantation and the placenta: key pieces of the development puzzle. Science, 266, 1508-1518.
7. Damsky CH, Librach C, Lim KH, Fitzgerald ML, McMaster MT, Janatpour M, Zhou Y, Logan SK & Fisher SJ (1994) Integrin switching regulates normal trophoblast invasion. Development, 120, 3657-3666.
8. Dorudi S, Sheffield JP, Poulsom R, Northover JM & Hart IR (1993) E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol, 142, 981-986.
9. Floridon C, Nielsen O, Holund B, Sunde L, Westergaard JG, Thomsen SG & Teisner B (2000) Localization of E-cadherin in villous, extravillous and vascular trophoblasts during intrauterine, ectopic and molar pregnancy. Mol Hum Reprod, 6, 943-950.
10. Friedlander DR, Zagzag D, Shiff B, Cohen H, Allen JC, Kelly PJ & Grumet M (1996) Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves αVβ1 integrins. Cancer Res, 56, 1939-1947.
11. Ginsberg MH, Du X & Plow EF (1992) Inside-out integrin signalling. Curr Opin Cell Biol, 4, 766-771.
12. Hirano S, Nose A, Hatta K, Kawakami A & Takeichi M (1987) Calcium-dependent cell-cell adhesion molecules (cadherins): subclass specificities and possible involvement of actin bundles. J Cell Biol, 105, 2501-2510.
13. Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol, 153, 333-339.
14. Hsu M-Y, Meier F, Nesbit M, Hsu J-Y & Herlyn M (2000) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156, 1515-1525.
15. Hustin J, Jauniaux E & Schapps JP (1990) Histological study of the materno-embryonic interface in spontaneous abortion. Placenta, 11, 477-486.
16. Kantak SS & Kramer RH (1998) E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells. J Biol Chem, 273, 16953-16961.
17. Kemler R (1993) From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet, 9, 317-321.
18. Kurman RJ (1991) The morphology, biology, and pathology of intermediate trophoblast: a look back to the present. Hum Pathol, 22, 847-855.
19. Kurman RJ, Main CS & Chen HC (1984) Intermediate trophoblast: a distinctive form of trophoblast with specific morphological, biochemical and functional features. Placenta, 5, 349-370.
20. Lala PK & Hamilton GS (1996) Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta, 17, 545-555.
21. Loke YW & King A (1995) Trophoblast interaction with extracellular matrix, 1st Edn (Eds) Loke LW & King A. Cambridge: Cambridge University Press.
22. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, Kovats S, Damsky C & Fisher SJ (1995) Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol, 154, 3771-3778.
23. Morton RA, Ewing CM, Nagafuchi A, Tsukita S & Isaacs WB (1993) Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res, 53, 3585-3590.
24. Muhlhauser J, Crescimanno C, Kaufmann P, Hofler H, Zaccheo D & Castellucci M (1993) Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R. J Histochem Cytochem, 41, 165-173.
25. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG & Carosella ED (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA, 95, 4510-4515.
26. Perl AK, Wilgenbus P, Dahl U, Semb H & Christofori G (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature, 392, 190-193.
27. Redfield A, Nieman MT & Knudsen KA (1997) Cadherins promote skeletal muscle differentiation in three-dimenstional cultures. J Cell Biol, 138, 1323-1331.
28. Schipper JH, Frixen UH, Behrens J, Unger A, Jahnke K & Birchmeier W (1991) E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res, 51, 6328-6337.
29. Schulte AM, Lai S, Kurtz A, Czubayko F, Riegel AT & Wellstein A (1996) Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci USA, 93, 14759-14764.
30. Shih I-M & Kurman RJ (1996) Expression of melanoma cell adhesion molecule in intermediate trophoblast. Lab Invest, 75, 377-388.
31. Shih I-M & Kurman RJ (1998) Epithelioid trophoblastic tumor - A neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma. Am J Surg Pathol, 22, 1393-1403.
32. Shih I-M & Kurman RJ (2002) Molecular basis of gestational trophoblastic diseases. Curr Mol Med, 2, 1-12.
33. Shih I-M, Mazur MT & Kurman RJ (1999a) Gestational trophoblastic disease. In Diagnostic surgical pathology (Ed.) Sternberg SS, pp. 2067-2086. New York: Lippincott Williams & Wilkins Publishers.
34. Shih I-M, Seidman JD & Kurman RJ (1999b) Placental site nodule and characterization of distinctive types of intermediate trophoblast. Hum Pathol, 30, 687-694.
35. Shih I-M, Nesbit M, Herlyn M & Kurman RJ (1998a) A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol, 11, 1098-1106.
36. Shih I-M, Wang T-L, Wu T, Kurman RJ & Gearhart JD (1998b) Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J Cell Sci, 111, 2655-2664.
37. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi K, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M, et al. (1991) Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol, 139, 17-23.
38. Singer G, Kurman RJ, McMaster MT & Shih I-M (2002) HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol, 26, 914-920.
39. Takeichi M (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol, 5, 806-811.
40. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM & Isaacs WB (1992) Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res, 52, 5104-5109.
41. Vicovac L & Aplin JD (1996) Epithelial-mesenchymal transition during trophoblast differentiation. Acta Anatomica, 156, 202-216.
42. Vicovac L, Jones CJ & Aplin JD (1995) Trophoblast differentiation during formation of anchoring villi in a model of the early human placenta in vitro. Placenta, 16, 41-56.
43. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W & van Roy F (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-119.
44. Wang Z, Seliger B, Mike N, Momburg F, Knuth A & Ferrone S (1998) Molecular analysis of the HLA-A2 antigen loss by melanoma cells SK-MEL-29.1.22 and SK-MEL-29.1.29. Cancer Res, 58, 2149-2157.
45. Yagel S, Parhar RS, Jeffrey JJ & Lala PK (1988) Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol, 136, 455-462.
46. Yap AS (1998) The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review. Cancer Invest, 16, 252-261.
47. Zhou Y, Damsky CH & Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. J Clin Invest, 99, 2152-2164.
48. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Kdjana E, Wheelock M & Damsky CH (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate: A strategy for successful endovascular invasion? J Clin Invest, 99, 2139-2151.